Phyto-oestrogens and the endometrium

Lancet

Volumn 364, Issue 9451, 2004, Pages 2081-2082

  Arici, Aydin ^a   Bukulmez, Orhan ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CLOMIFENE CITRATE; DAIDZIN; ESTRADIOL; GENISTEIN; GLYCITEIN; ISOFLAVONE; PHYTOESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

CELL PROLIFERATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; HUMAN; INTRAUTERINE INSEMINATION; LABORATORY DIAGNOSIS; MENOPAUSAL SYNDROME; NOTE; POSTMENOPAUSE; PRIORITY JOURNAL; STROMA CELL; UTERUS;

EID: 10344242933     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17565-X     Document Type: Note

References (19)

1. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril. 82:2004;145-148
2. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. High dose of phytoestrogens can reverse the antiestrogenic effects of clomiphene citrate on the endometrium in patients undergoing intrauterine insemination: a randomized trial. J Soc Gynecol Investig. 11:2004;323-328
3. St Clair RW. Estrogens and atherosclerosis: phytoestrogens and selective estrogen receptor modulators. Curr Opin Lipidol. 9:1998;457-463
4. Kayisli UA, Aksu CA, Berkkanoglu M, Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab. 87:2002;5539-5544
5. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab. 80:1995;1685-1690
6. Murray MJ, Meyer WR, Lessey BA, Oi RH, DeWire RE, Fritz MA. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women. Menopause. 10:2003;456-464
7. Clark TJ, Ter Riet G, Coomarasamy A, Khan KS. Bias associated with delayed verification in test accuracy studies: accuracy of tests for endometrial hyperplasia may be much higher than we think! BMC Med. 2:2004;18
8. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia: a long-term study of "untreated" hyperplasia in 170 patients. Cancer. 56:1985;403-412
9. Terakawa N, Kigawa J, Taketani Y, et al. The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group. J Obstet Gynaecol Res. 23:1997;223-230
10. Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review. Obstet Gynecol Surv. 59:2004;368-378
11. Lethaby A, Suckling J, Barlow D, Farquhar C, Jepson R, Roberts H. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev. 3:2004;CD000402
12. Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA. 275:1996;370-375
13. Johnson EB, Muto MG, Yanushpolsky EH, Mutter GL. Phytoestrogen supplementation and endometrial cancer. Obstet Gynecol. 98:2001;947-950
14. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric. 2:1999;79-84
15. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol. 20:2002;1449-1455
16. Han KK, Soares JM, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol. 99:2002;389-394
17. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors. J Clin Oncol. 18:2000;1068-1074
18. Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril. 79:2003;1112-1117
19. Somekawa Y, Chiguchi M, Ishibashi T, Wakana K, Aso T. Efficacy of ipriflavone in preventing adverse effects of leuprolide. J Clin Endocrinol Metab. 86:2001;3202-3206